CG Oncology Inc.(CGON:US)

Market Cap$5.285B

Key Metrics

Price$59.85

Revenue (TTM)$6.23M

Holders Revenue (TTM)-

Gross Profit (TTM)-$5.31M

Earnings (TTM)-$224.38M

EBITDA (TTM)-$249.66M

Op. Margin (TTM)-4.06K%

Dividend Yield-

Holders Yield-

Cash on hand$19.64M

Total Assets$1.086B

Net Assets$1.029B

Total Debt$8.82M

CG Oncology Inc.(CGON:US)

Market Cap$5.285B

Price history

Key Metrics

Price$59.85

Revenue (TTM)$6.23M

Holders Revenue (TTM)-

Gross Profit (TTM)-$5.31M

Earnings (TTM)-$224.38M

EBITDA (TTM)-$249.66M

Op. Margin (TTM)-4.06K%

Dividend Yield-

Holders Yield-

Cash on hand$19.64M

Total Assets$1.086B

Net Assets$1.029B

Total Debt$8.82M

Financials

NameJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Revenue
$1.16M$1.08M$2.32M$1.67M$0$52K$456K$43K$111K$529K$1K$9K$0$194K$0
Cost of Revenue
$3.93M$2.96M$3.07M$1.58M-----------
Gross Profit
-$2.77M-$1.88M-$748K$89K-----------
$83.63M$64.51M$47.95M$51.22M$48.74M$42.26M$38.51M$28.34M$25.96M$23M$18.93M$14.05M$12.33M$9.92M$9.32M
Research and Development$54.66M$43.73M$29.96M$27.88M$31.33M$27.47M$26.8M$19.62M$18.47M$17.21M$15.92M$11.74M$9.83M$7.84M$7.66M
Selling, General, and Administrative$28.98M$20.78M$17.99M$23.33M$17.41M$14.79M$11.71M$8.72M$7.49M$5.79M$3.02M$2.32M$2.49M$2.07M$1.66M
Other Operating Expenses---------------
Operating Income
-$86.4M-$66.39M-$48.7M-$51.13M-$48.74M-$42.2M-$38.05M-$28.3M-$25.85M-$22.47M-$18.93M-$14.04M-$12.33M-$9.72M-$9.32M
$7.35M$6.19M$7.39M$7.32M$7.32M$7.75M$6.25M$7.89M$6.95M$5.54M-$4K$2.28M$713K$1.05M$13K
Non-Operating Interest Income$7.33M$6.29M$7.44M$7.42M$7.32M$7.75M$6.25M$7.89M$6.94M$5.55M-$2.28M$771K$1.05M-
Non-Operating Interest Expense---------------
Other Income/Expense$16K-$101K-$53K-$100K-$4K$5K$6K-$2K$8K-$9K-$4K-$8K-$58K$8K$13K
Income Before Tax
-$79.06M-$60.2M-$41.31M-$43.81M-$41.43M-$34.45M-$31.8M-$20.41M-$18.9M-$16.93M-$16.12M-$11.77M-$11.61M-$8.67M-$8.39M
Income Tax
---------------
Net Income
-$79.06M-$60.2M-$41.31M-$43.81M-$41.43M-$34.45M-$31.8M-$20.41M-$18.9M-$16.93M-$16.12M-$11.77M-$11.61M-$8.67M-$8.39M
Minority Interests
---------------
Preferred Stock Dividends
---------------
Net Income to Common
-$79.06M-$60.2M-$41.31M-$43.81M-$41.43M-$34.45M-$31.8M-$20.41M-$18.9M-$16.93M-$16.12M-$11.77M-$11.61M-$8.67M-$8.39M
Shares Outstanding (Basic)
88.2M84.52M-76.73M76.23M76.19M-67.14M66.65M47.06M-63.48M63.48M4.33M-
Shares Outstanding (Diluted)
88.2M84.52M-76.73M76.23M76.19M-67.14M66.65M47.06M-63.48M63.48M4.33M-
EPS (Basic)
-$0.90-$0.71--$0.57-$0.54-$0.45--$0.30-$0.28-$0.36--$0.28-$0.24-$2.86-
EPS (Diluted)
-$0.90-$0.71--$0.57-$0.54-$0.45--$0.30-$0.28-$0.36--$0.28-$0.24-$2.86-
EBIT
-$86.4M-$66.39M-$48.7M-$51.13M-$48.74M-$42.2M-$38.05M-$28.3M-$25.85M-$22.47M-$18.93M-$14.04M-$12.33M-$9.72M-$9.51M
EBITDA
-$85.55M-$65.55M-$47.85M-$50.71M-$48.59M-$42.18M-$38.05M-$28.27M-$25.85M-$22.47M-$18.93M-$14.04M-$12.32M-$9.72M-$9.51M